提名 发表于 2025-3-28 14:53:37

Einführung in die theoretische Gasdynamikin practical clinical science. Substitutive administration of a new concentrate of a human immunoglobulin (IgG) preparation resulted in regular minimal platelet increases in a child with a primary immunodeficiency and low platelet counts despite normal platelet production. The investigators conclude

Glaci冰 发表于 2025-3-28 22:41:14

Einführung in die theoretische Gasdynamikestones in the history of human immunoglobulins since the initial observation by Ogden C. Bruton who described replacement therapy in a single boy with agammaglobulinemia. Since then, the preparations used for treatment have been markedly improved with respect to tolerability, clinical efficacy, and

excursion 发表于 2025-3-28 23:11:57

http://reply.papertrans.cn/16/1585/158479/158479_43.png

重力 发表于 2025-3-29 04:24:39

Kapitel 7: Erfassung sozialer Phänomeneoimmune syndromes. Although the precise mechanism of action of IVIg as an immunomodulatory agent has been elusive, many theories over the years have been postulated. These theories include mononuclear phagocytic system blockade, autoantibody neutralization, increased clearance of pathogenic autoanti

RENIN 发表于 2025-3-29 08:53:31

http://reply.papertrans.cn/16/1585/158479/158479_45.png

整洁漂亮 发表于 2025-3-29 15:11:12

Kapitel 10: Theorien der Gegenwartously untreatable, or poorly managed, conditions. Based on controlled trials, IVIg is approved as first-line therapy for patients with GBS, CIDP, and multifocal motor neuropathy. In CIDP, where the largest controlled study was performed, IVIg is also effective in the chronic management of the diseas

Hippocampus 发表于 2025-3-29 18:47:07

Kapitel 6: Grundbegriffe und Datenerhebungwhen Furusho et al. (1984) and Newburger et al. (1986), respectively, reported the successful application of IVIg in Kawasaki syndrome. Seven years later, Dalakas et al. (1993) reported the first successful randomized controlled trial of IVIg in the treatment of dermatomyositis. Ever since, IVIg has

业余爱好者 发表于 2025-3-29 23:13:03

http://reply.papertrans.cn/16/1585/158479/158479_48.png

季雨 发表于 2025-3-30 02:25:00

http://reply.papertrans.cn/16/1585/158479/158479_49.png

离开可分裂 发表于 2025-3-30 04:39:30

http://reply.papertrans.cn/16/1585/158479/158479_50.png
页: 1 2 3 4 [5] 6
查看完整版本: Titlebook: Antibody Therapy; Substitution – Immun Paul Imbach Book 2018 Springer International Publishing AG, part of Springer Nature 2018 Immunoglobu